S
Suzanne Oparil
Researcher at University of Alabama at Birmingham
Publications - 941
Citations - 122414
Suzanne Oparil is an academic researcher from University of Alabama at Birmingham. The author has contributed to research in topics: Blood pressure & Angiotensin II. The author has an hindex of 106, co-authored 885 publications receiving 113983 citations. Previous affiliations of Suzanne Oparil include Michigan State University & Oregon Health & Science University.
Papers
More filters
Journal ArticleDOI
Essential Hypertension Part I: Definition and Etiology
TL;DR: This review of current concepts regarding the definition, etiology, and treatment of essential hypertension is intended to aid the clinician in identifying those individuals at high risk who need to undergo evaluation and treatment, as well as in selecting optimal treatment strategies for hypertensive patients with comorbid conditions and/or target organ damage.
Journal ArticleDOI
Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women
Lori Mosca,Lawrence J. Appel,Emelia J. Benjamin,Kathy Berra,Nisha Chandra-Strobos,Rosalind P. Fabunmi,Deborah Grady,Constance K. Haan,Sharonne N. Hayes,Debra R. Judelson,Nora L. Keenan,Patrick McBride,Suzanne Oparil,Pamela Ouyang,Mehmet C. Oz,Michael E. Mendelsohn,Richard C. Pasternak,Vivian W. Pinn,Rose Marie Robertson,Karin Schenck-Gustafsson,Cathy A. Sila,Sidney C. Smith,George Sopko,Anne L. Taylor,Brian W. Walsh,Nanette K. Wenger,Christine L. Williams +26 more
TL;DR: In the wake of the reports of the Women’s Health Initiative and the Heart and Estrogen/Progestin Replacement Study, which unexpectedly showed that combination hormone therapy was associated with adverse CVD effects, there is a heightened need to critically review and document strategies to prevent CVD in women.
Journal ArticleDOI
Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial.
Jeff D. Williamson,Mark A. Supiano,Mark A. Supiano,William B. Applegate,Dan R. Berlowitz,Dan R. Berlowitz,Ruth C. Campbell,Glenn M. Chertow,Larry J. Fine,William E. Haley,Amret T. Hawfield,Joachim H. Ix,Joachim H. Ix,Dalane W. Kitzman,John B. Kostis,Marie Krousel-Wood,Lenore J. Launer,Suzanne Oparil,Carlos J. Rodriguez,Christianne L. Roumie,Christianne L. Roumie,Ronald I. Shorr,Ronald I. Shorr,Kaycee M. Sink,Virginia G. Wadley,Paul K. Whelton,Jeff Whittle,Jeff Whittle,Nancy Woolard,Jackson T. Wright,Nicholas M. Pajewski +30 more
TL;DR: Among ambulatory adults aged 75 years or older, treating to an SBP target of less than 120 mm Hg compared with an SBp target of more than 140mm Hg resulted in significantly lower rates of fatal and nonfatal major cardiovascular events and death from any cause.
Journal ArticleDOI
Feasibility of Treating Prehypertension with an Angiotensin-Receptor Blocker
Stevo Julius,Shawna D. Nesbitt,Brent M. Egan,Michael A. Weber,Eric L. Michelson,Niko Kaciroti,Henry R. Black,Richard H. Grimm,Franz H. Messerli,Suzanne Oparil,M. Anthony Schork +10 more
TL;DR: Treatment of prehypertension with candesartan appeared to be well tolerated and reduced the risk of incident hypertension during the study period, and treatment of pre Hypertension appears to be feasible.
Journal ArticleDOI
Evidence-based guidelines for cardiovascular disease prevention in women: 2007 Update
Lori Mosca,Carole L. Banka,Emelia J. Benjamin,Kathy Berra,Cheryl Bushnell,Rowena J. Dolor,Theodore G. Ganiats,Antoinette S. Gomes,Heather L. Gornik,Clarissa Gracia,Martha Gulati,Constance K. Haan,Debra R. Judelson,Nora L. Keenan,Ellie Kelepouris,Erin D. Michos,L. Kristin Newby,Suzanne Oparil,Pamela Ouyang,Mehmet C. Oz,D. Petitti,Vivian W. Pinn,Rita F. Redberg,Rosalyn P. Scott,Katherine Sherif,Sidney C. Smith,George Sopko,Robin H. Steinhorn,Neil J. Stone,Kathryn A. Taubert,Barbara A. Todd,Elaine M. Urbina,Nanette K. Wenger +32 more
TL;DR: The burden of CVD on women and the global economy will continue to increase as life expectancy continues to increase and economies become more industrialized.